James Scott, MD
Surgery · Saint Louis, MONPI 1134115637
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 98.7% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2021 at $87,555 and has fallen 92.2% since, to $6,809 in 2025. Among surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $832.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$303K
- Johnson & Johnson$2K
- Endogastric Solutions, Inc$1K
- AbbVie$298
- TELA Bio, Inc.$127
- Covidien LP$112
- plus $662 from 22 others
What the payments were for
- Consulting fees$24,5758%
- Speaking & faculty fees$110,25036%
- Travel & lodging$28,8269%
- Food & beverage$7,6702%
- Education$135,50044%
- Gifts$1990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 303 | $302,915 |
| Johnson & Johnson(2 entities) | 11 | $1,791 |
| Endogastric Solutions, Inc | 4 | $1,114 |
| AbbVie | 17 | $298 |
| TELA Bio, Inc. | 3 | $127 |
| Covidien LP | 2 | $112 |
| Apollo Endosurgery US Inc | 1 | $112 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Kerecis Limited | 2 | $41 |
| Organogenesis Inc. | 1 | $27 |
| Acera Surgical, Inc. | 1 | $27 |
| Medtronic | 2 | $27 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| BD | 1 | $23 |
| Ambu Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Polynovo North America LLC | 1 | $20 |
| Vertex | 1 | $20 |
| Standard Bariatrics, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Lifenet Health | 2 | $16 |
| Olympus America Inc. | 1 | $15 |
| Mesh Suture Inc | 1 | $14 |
| Rhythm Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Merit Medical Systems Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$298,565
- DA VINCI SP$2,150
- ESOPHYX$1,114
- Overstitch$112
How this compares
$307,019 in reported general payments places this provider in the 95th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 13 | $580,012 |
| CreonLipase/Protease/Amylase | 65 | $50,689 |
| LinzessLinaclotide | 45 | $30,111 |
| Ondansetron OdtOndansetron | 66 | $1,661 |
| Sucralfate | 32 | $1,365 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,231 |
| Pantoprazole Sodium | 60 | $963 |
| Omeprazole | 76 | $860 |
| Colestipol Hcl | 14 | $794 |
| Clindamycin Hcl | 55 | $431 |
| Clotrimazole | 43 | $404 |
| Gabapentin | 28 | $298 |
| Acarbose | 11 | $289 |
| Amitriptyline Hcl | 21 | $69 |
| Potassium Chloride | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $58 | $580,01213 claims |
| AbbVieCreon, Linzess | $298 | $80,799110 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 612 surgery providers in Missouri.
Other surgery in Saint Louis
- Omar GuerraSaint Louis$249K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Sekhar DharmarajanSaint Louis$110K
- Shaina EckhouseSaint Louis$67K
- Jason RheeSaint Louis$63K
- Christopher LawranceSaint Louis$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.